XORTX Therapeutics (XRTX) Gains from Equity Investments (2021 - 2026)
XORTX Therapeutics (XRTX) posted Gains from Equity Investments of -$7000.0 for Q1 2026, up 92.47% on a QoQ basis from -$93000.0 in Q4 2025, and up 97.15% year-over-year from -$3550.5 in Q1 2025.
XORTX Therapeutics (XRTX) Gains from Equity Investments (2021 - 2026) Analysis & Trends
XORTX Therapeutics' Gains from Equity Investments history runs 5 years deep, the most recent figure standing at -$7000.0 for Q1 2026.
- Quarterly Gains from Equity Investments rose 97.15% year-over-year to -$7000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$325000.0 (up 65.27% YoY) and the FY2025 annual result came in at -$564000.0, down 154.49% from the prior year.
- Gains from Equity Investments was -$7000.0 for Q1 2026 at XORTX Therapeutics, up from -$93000.0 in the prior quarter.
- Across five years, Gains from Equity Investments topped out at $1.7 million in Q1 2024 and bottomed at -$1.6 million in Q2 2024.
- A 4-year average of -$225671.7 and a median of -$244000.0 in 2024 frame the typical range for Gains from Equity Investments.
- Annual changes were most pronounced in 2022 — Gains from Equity Investments plunged 131.32% — and 2026, when it jumped 97.15%.
- XORTX Therapeutics' Gains from Equity Investments stood at -$1.6 million in 2022, then soared by 175.94% to $1.2 million in 2024, then sank by 107.75% to -$93000.0 in 2025, then jumped by 92.47% to -$7000.0 in 2026.
- Business Quant data shows XRTX's Gains from Equity Investments at -$7000.0 in Q1 2026, -$93000.0 in Q4 2025, and -$76000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | XORTX Therapeutics | 20.40 Mn | 20.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7,000.00 |
| Mar 31, 2026 | -7,000.00 |
| Dec 31, 2025 | -93,000.00 |
| Dec 31, 2025 | -93,000.00 |
| Sep 30, 2025 | -76,000.00 |
| Sep 30, 2025 | -76,000.00 |
| Jun 30, 2025 | -149,000.00 |
| Jun 30, 2025 | -149,000.00 |
| Mar 31, 2025 | -246,000.00 |
| Mar 31, 2025 | -246,000.00 |
| Dec 31, 2024 | 1.20 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | -244,000.00 |
| Sep 30, 2024 | -244,000.00 |
| Jun 30, 2024 | -1.65 Mn |
| Jun 30, 2024 | -1.65 Mn |
| Mar 31, 2024 | 1.72 Mn |
| Mar 31, 2024 | 1.72 Mn |
| Dec 31, 2022 | -1.58 Mn |
| Dec 31, 2022 | -1.58 Mn |